BF

Baekeland Funds

Europe, Gelderland, The Netherlands, Gent

Description

Baekeland Funds is a seed capital fund formed to invest in companies developed at the University of Ghent.

Investor Profile

Baekeland Funds has made 13 investments, with 0 in the past 12 months and 8% as lead.

Stage Focus

  • Series Unknown (54%)
  • Series B (15%)
  • Series A (15%)
  • Series C (8%)
  • Private Equity (8%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biotechnology
  • Hardware
  • Software
  • Health Care
  • Health Diagnostics
  • Analytics
  • Therapeutics
  • Biopharma
  • Clinical Trials
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Baekeland Funds frequently co-invest with?

Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 6
Capital-E
North America, District of Columbia, United States, Washington
Co-Investments: 2
Gemma Frisius Fund
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 3
VIB
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 3
Vesalius Biocapital Partners
Europe, Luxembourg, Luxembourg, Strassen
Co-Investments: 3
KBC
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 3
Capricorn Partners
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
F
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 4
BF
Europe, Antwerpen, Belgium, Antwerp
Co-Investments: 3

What are some of recent deals done by Baekeland Funds?

Complix

Diepenbeek, Limburg, Belgium

Complix is a biopharmaceutical company developing Alphabodies, a novel class of biopharmaceuticals.

BiotechnologyHealth CareTherapeutics
Series BJun 26, 2013
Amount Raised: $15,621,929
Trinean

Gentbrugge, Oost-Vlaanderen, Belgium

Trinean is a Belgium based technology provider, bringing micro-volume molecular spectroscopy to the next level.

AnalyticsBiotechnologyHardwareSoftware
Series UnknownApr 27, 2012
Amount Raised: $4,900,636
Caliopa

Zwijnaarde, Oost-Vlaanderen, Belgium

Caliopa develops and commercializes silicon photonics-based optical transceivers for the data and telecommunications market.

SemiconductorTelecommunicationsWeb Hosting
Series UnknownSep 24, 2010
Amount Raised: $2,694,005
Sigasi

Gentbrugge, Oost-Vlaanderen, Belgium

Sigasi creates an Intelligent Development Environment (IDE) for hardware designers that helps them write, inspect, and modify designs.

HardwareSoftware
Series AJul 29, 2010
Pronota

Ghent, Oost-Vlaanderen, Belgium

Pronota develops diagnostic devices for the early detection of conditions such as heart failure, pre-eclampsia and sepsis.

BiotechnologyHealth CareHealth Diagnostics
Series BJun 29, 2009
Amount Raised: $7,360,000
ActoGeniX

Zwijnaarde, Oost-Vlaanderen, Belgium

A biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs.

BiopharmaBiotechnologyClinical TrialsPharmaceutical
Private EquityFeb 11, 2009
Amount Raised: $17,424,773
Aristo Music Technology

Hasselt, Limburg, Belgium

Aristo Music provides music-related services, and develops selection and distribution techniques and technologies for digital music.

Customer ServiceMusic
Series UnknownNov 25, 2008
Amount Raised: $3,380,000
Trinean

Gentbrugge, Oost-Vlaanderen, Belgium

Trinean is a Belgium based technology provider, bringing micro-volume molecular spectroscopy to the next level.

AnalyticsBiotechnologyHardwareSoftware
Series UnknownOct 17, 2008
Amount Raised: $4,710,000
Algonomics

Bel, Antwerpen, Belgium

Algonomics provides structural bioinformatics services to develop rationally designed therapeutics in the field of immunotherapy.

BioinformaticsBiotechnologyTherapeutics
Series UnknownJun 20, 2007
Amount Raised: $2,013,307
ActoGeniX

Zwijnaarde, Oost-Vlaanderen, Belgium

A biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs.

BiopharmaBiotechnologyClinical TrialsPharmaceutical
Series UnknownSep 19, 2006
Amount Raised: $25,351,145